Cover Image
Market Research Report

Global Label-free Detection (LFD) Market 2017-2021

Published by TechNavio (Infiniti Research Ltd.) Product code 563427
Published Content info 76 Pages
Delivery time: 1-2 business days
Back to Top
Global Label-free Detection (LFD) Market 2017-2021
Published: September 28, 2017 Content info: 76 Pages

About Label-free Detection (LFD)

LFD technology is used in the process of drug discovery. The main use of LFD technology is kinetics and analysis during drug discovery. LFD technology is widely used for end-point screening and specificity testing. Some of the benefits of LFD technology include faster turnaround time, real-time kinetic analysis, and others. LFD technology has replaced radioactive assay and enzyme-linked immunosorbent assay (ELISA). It helps study the interaction between drug and target.

Technavio's analysts forecast the global label-free detection (LFD) market to grow at a CAGR of 10.76% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global label-free detection (LFD) market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Label-free Detection (LFD) Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Bio-Rad Laboratories
  • GE Healthcare
  • F.Hoffman-La Roche

Other Prominent Vendors

  • Attana
  • BiOptix
  • Corning
  • Juno Therapeutics
  • Pall
  • SymCel

Market driver

  • Rise in drug discovery programs
  • For a full, detailed list, view our report

Market challenge

  • Strained laboratory budgets and decline in reimbursement
  • For a full, detailed list, view our report

Market trend

  • Potential opportunities for POL
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents
Product Code: IRTNTR14699

Table of Contents

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

  • Market outline

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Market segmentation by product

  • Market overview
  • Biochemical assays
  • Cell-based assays

PART 07: Market segmentation by end-user

  • Market overview

PART 08: Geographical segmentation

  • Market overview
  • Americas
  • EMEA
  • APAC

PART 09: Decision framework

PART 10: Drivers and challenges

  • Market drivers
  • Market challenges

PART 11: Market trends

  • Potential opportunities for POL
  • Advances in technology

PART 12: Vendor landscape

  • Competitive analysis

PART 13: Key vendor analysis

  • Bio-Rad Laboratories
  • GE Healthcare
  • F. Hoffman-La Roche
  • Key company to watch
  • Other prominent vendors

PART 14: Appendix

  • List of abbreviations

List of Exhibits

  • Exhibit 01: Global LFD market 2016-2021: Overview
  • Exhibit 02: Global LFD market 2016-2021 ($ billions)
  • Exhibit 03: Five forces analysis
  • Exhibit 04: Global LFD market by product 2016-2021: Overview
  • Exhibit 05: Global biochemical assays market 2016-2021 ($ billions)
  • Exhibit 06: Impact assessment for global biochemical assays market 2016-2021
  • Exhibit 07: Global cell-based assays market 2016-2021 ($ billions)
  • Exhibit 08: Impact assessment for global cell-based assays market 2016-2021
  • Exhibit 09: Global LFD by end-user 2016-2021: Overview
  • Exhibit 10: Global LFD market segmentation by end-user 2016
  • Exhibit 11: Impact assessment of global LFD market 2016-2021
  • Exhibit 12: Global LFD market by geography 2016-2021: Overview
  • Exhibit 13: LFD market in Americas 2016-2021: Overview
  • Exhibit 14: LFD market in Americas 2016-2021 ($ billions)
  • Exhibit 15: LFD market in Americas: Future outlook
  • Exhibit 16: Americas: Market metrics in various countries
  • Exhibit 17: LFD market in EMEA 2016-2021: Overview
  • Exhibit 18: LFD market in EMEA 2016-2021 ($ billions)
  • Exhibit 19: EMEA: Market metrics in various countries
  • Exhibit 20: LFD market in EMEA: Future outlook
  • Exhibit 21: LFD market in APAC 2016-2021: Overview
  • Exhibit 22: LFD market in APAC 2016-2021 ($ billions)
  • Exhibit 23: APAC: Market metrics in various countries
  • Exhibit 24: LFD market in APAC: Future outlook
  • Exhibit 25: Competitive structure analysis of global LFD market 2016
  • Exhibit 26: Competitive analysis of global LFD market 2016
  • Exhibit 27: Strategic success factors of companies in global LFD market
  • Exhibit 28: Bio-Rad Laboratories: Key highlights
  • Exhibit 29: Bio-Rad Laboratories: Strength assessment
  • Exhibit 30: Bio-Rad Laboratories: Strategy assessment
  • Exhibit 31: Bio-Rad Laboratories: Opportunity assessment
  • Exhibit 32: GE Healthcare: Key highlights
  • Exhibit 33: GE Healthcare: Strength assessment
  • Exhibit 34: GE Healthcare: Strategy assessment
  • Exhibit 35: GE Healthcare: Opportunity assessment
  • Exhibit 36: F. Hoffmann-La Roche: Key highlights
  • Exhibit 37: F. Hoffmann-La Roche: Strength assessment
  • Exhibit 38: F. Hoffmann-La Roche: Strategy assessment
  • Exhibit 39: F. Hoffmann-La Roche: Opportunity assessment
  • Exhibit 40: PerkinElmer: Company analysis
Back to Top